FULU HOLDINGS (02101) announced its interim results, with a profit attributable to shareholders of 23.062 million yuan, a decrease of 23.5% year-on-year.

21:31 27/08/2026

Fulu Holdings (02101) released its interim results for 2026, reporting a revenue of 113 million RMB, a year-on-year decrease of 28.4%; the profit attributable to equity holders of the parent company was 23.062 million, a year-on-year decrease of 23.5%; basic earnings per share were 0.06 yuan.

FULU HOLDINGS (02101) released its interim results for 2026, reporting revenue of 113 million yuan, a year-on-year decrease of 28.4%; profit attributable to equity holders of the parent company was 23.062 million yuan, down 23.5% year-on-year; basic earnings per share were 0.06 yuan.

VISEN PHARMA-B (02561) core product approved for commercialization, achieving revenue of 34.542 million yuan in the first half of the year.

LONGHUI INTL (01007) announced its 2024 annual results, with a loss attributable to shareholders of 18.989 million yuan, an increase of 32.3% year-on-year.

YE XING GROUP (01941) announced its interim results, with shareholders' profit attributable to them amounting to 17.146 million yuan, representing a year-on-year increase of 33.88%.

VISEN PHARMA-B (02561) core product approved for commercialization, achieving revenue of 34.542 million yuan in the first half of the year.

LONGHUI INTL (01007) announced its 2024 annual results, with a loss attributable to shareholders of 18.989 million yuan, an increase of 32.3% year-on-year.

YE XING GROUP (01941) announced its interim results, with shareholders' profit attributable to them amounting to 17.146 million yuan, representing a year-on-year increase of 33.88%.